IMMUNIC, INC.
Company Stats
- Market Cap
- $126.9M
- as of Sep 30, 2026
- Shares Outstanding
- 13.6M
- Free Float
- 25.6%
Income Statement
- Operating Income
- -$103.2M
- Net Income
- -$97.2M
- EBITDA
- -$103.1M
Cash Flow
- Free Cash Flow
- -$86.0M
- FCF Yield
- -67.7%
- Owner FCF Yield
- -74.7%
Balance Sheet
- Cash & Equivalents
- $15.5M
Returns & Capital
- SBC, 3Y Avg
- $8.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$86.0M | — |
| FY2024 | — | -$85.0M | — |
| FY2023 | — | -$71.2M | — |
| FY2022 | — | -$65.3M | — |
| FY2021 | — | -$83.3M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges